Question 1

What are the potential benefits of participating in this trial for my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine clinical trial (NCT00002096). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the trial affect my current HIV medication regimen?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine clinical trial (NCT00002096). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of while taking ganciclovir with AZT or ddI?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine clinical trial (NCT00002096). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit the clinic if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine clinical trial (NCT00002096). Contact the study team or your healthcare provider for specific answers.

Question 5

What tests or monitoring will be required during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine clinical trial (NCT00002096). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks associated with taking ganciclovir that I should know about?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine clinical trial (NCT00002096). Contact the study team or your healthcare provider for specific answers.

What this study is about